Current and Emerging Applications of Fecal Microbiota Transplantation

Am J Nurs. 2023 Sep 7;Published Ahead of Print. doi: 10.1097/01.NAJ.0000978920.88346.77. Online ahead of print.ABSTRACTFecal microbiota transplantation (FMT) is a life-changing treatment for people with recurrent Clostridioides difficile infection (rCDI). Frequently acquired in the hospital, CDI can cause serious gastrointestinal symptoms, including persistent watery diarrhea, abdominal pain, and severe dehydration. Antibiotics, the primary treatment, can unfortunately disrupt the gut microbiome and lead to antimicrobial resistance. FMT involves introducing stool from a healthy donor into the affected recipient to strengthen their compromised microbiome. Individuals receiving this treatment have reported remarkable improvement in clinical outcomes and quality of life. In addition to a discussion of rCDI within the context of the gastrointestinal microbiome, this article provides an overview of the FMT procedure, discusses nursing management of individuals undergoing FMT, and highlights emerging applications beyond rCDI. A case scenario is also provided to illustrate a typical trajectory for a patient undergoing FMT.PMID:37678377 | DOI:10.1097/01.NAJ.0000978920.88346.77
Source: The American Journal of Nursing - Category: Nursing Authors: Source Type: research